Revive Therapeutics (RVV) Stock Price, News & Analysis

Company Overview

Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

Key Stats

• Today's Range: C$0.08 to C$0.09
• 50-Day Range: C$0.08 to C$0.08
• 52-Week Range: C$0.07 to C$0.25
• Volume: 212,852 shs
• Average Volume: 93,085 shs
• Market Capitalization: C$5.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RVV Stock Analysis - Frequently Asked Questions

How have RVV shares performed this year?

Revive Therapeutics' stock was trading at C$0.08 on January 1st, 2025. Since then, RVV shares have increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2025 here.

How do I buy shares of Revive Therapeutics?

Shares of RVV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Revive Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Revive Therapeutics investors own include Aurora Cannabis (ACB), IntelGenx Technologies (IGXT), Vaxart (VXRT), Plug Power (PLUG), Sorrento Therapeutics (SRNE), Green Organic Dutchman (TGOD) and Zoom Video Communications (ZM).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:RVV
• CIK: N/A
• Web: www.revivethera.com
• Phone: +1-905-6055535
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.14
• Quick Ratio: 6.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.03 per share
• Price / Cash Flow: 3.18
• Book Value: C$0.02 per share
• Price / Book: 4.21

Miscellaneous

• Outstanding Shares: 72,411,000
• Free Float: N/A
• Market Cap: C$5.79 million
• Optionable: Not Optionable
• Beta: N/A